Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STANDLOW: Low vs Standard Dose AEDs in Newly Diagnosed Epilepsy
NCT03689114Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- May 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carbamazepine, levetiracetam, valproic acid, zonisamide, oxcarbazepine in focal epilepsy, sponsored by Mario Negri Institute for Pharmacological Research. Started May 2021; status: completed.
02
Drugs
carbamazepinelevetiracetamvalproic acidzonisamideoxcarbazepine
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT03689114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689114.